Researchers from the University of Oxford’s Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine.
Influenza is thought to be a highly variable virus, able to mutate and escape immunity built up in the population due to its circulation in previous seasons. However, influenza seasons tend to be dominated by a limited number of antigenically and genetically distinct influenza viruses. This creates a paradox as influenza is thought of as being highly variable while in reality influenza seasons are dominated by only a few strains.
Mathematical models produced in Professor Sunetra Gupta’s group at the University of Oxford over the past 20 years have sought to find an answer to this paradox. Finally, through a collaborative approach across multiple departments, the group believes they have the answer, demonstrated in a paper published today in Nature Communications.
Dr Craig Thompson said: ‘The integrated approach to vaccine design that we have applied to flu has to the potential to be applied to other previously intractable pathogens and could revolutionise the way we develop vaccines.’
Professor Sunetra Gupta said: ‘I think this work serves a good example of how evolutionary models can have translational impact. We have gone from a prediction of a mathematical model to a blueprint for a universal influenza vaccine. The outstanding teamwork coordinated by Dr Thompson is what made it all possible.’
The research team theorized that parts of the virus targeted by the immune system are, in fact, limited in variability and act as constraints on the evolution of the virus. Dr Craig Thompson in Professor Gupta’s group has now identified the location of these regions of limited variability. He has shown that such locations are targeted naturally by the immune system and through vaccination studies has shown that regions of influenza viruses that circulated in 2006 and 1977 were able to protect against infection with an influenza virus that last circulated in 1934.
The results of these studies can be exploited to create a novel type of ‘universal’ or broadly protective influenza vaccine, which once administered would provide lifelong protection against influenza. The team also hopes to apply the approach to other viruses such as HIV and HCV and believes that they can use it to produce a vaccine that protects against the common cold. The novel approach to vaccine design is outlined in the paper published in Nature Communications. Furthermore, such vaccines should be able to be produced in a low-cost manner, enabling healthcare providers such as the NHS to save money, unlike many new vaccines and drugs coming to the market.
This study also presents one of the first examples of where a mathematical model of the evolutionary dynamics of an infectious disease has led to the experimental identification of a novel vaccine target. The novel approach won an MRC Confidence in Concept Award in 2016, a Royal Society Translational Award in 2017 and an ERC Proof of Concept grant in 2018.
The WHO estimates that influenza kills 260,000-650,000 people and causes 3-5 million cases of severe illness each year. This burden typically falls on the elderly and young children, especially in developing countries. The best way to protect against influenza is through vaccination, although the problem with this is that the current influenza vaccine has to be administered each year and varies in its effectiveness.
The Latest on: Universal flu vaccine
via Google News
The Latest on: Universal flu vaccine
- How effective are masks in preventing SARS-CoV-2 transmission?on January 11, 2021 at 6:34 am
Can face masks protect against SARS-CoV-2 infection? Faruque Ahmad, MD, recently explored the role of face masks in mitigating the coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2.
- Global Influenza (Flu) Antiviral Drugs Market 2020 Growth Factors, Product Overview, Segmentation and Forecast Study to 2025on January 10, 2021 at 7:45 pm
Antiviral Drugs Market 2020 by Company, Regions, Type and Application, Forecast to 2025 announced by MarketsandResearch.biz provides an expert and in-depth analysis of key business trends and future ...
- Researchers close in on 'universal' flu vaccine as COVID-19 fight takes priorityon January 8, 2021 at 12:21 pm
Researchers believe they are one step closer to a universal flu vaccine, even as concerns over the seasonal virus move to the back burner during the COVID-19 pandemic.
- Charles River Labs Acquires Antibody Partner Distributed Bio for Up to $104Mon January 5, 2021 at 5:30 am
Distributed Bio has been acquired by Charles River Laboratories—its antibody collaboration partner of 2+ years—for up to $104 million.
- The importance of the flu vaccine in the Year of COVIDon January 4, 2021 at 5:27 pm
As we await our turn to get the COVID vaccine, a flu shot may alleviate some of the uncertainty and help our health care system.
- Study: Mandating flu shots for hospital workers reduces viral spread, deathson January 4, 2021 at 2:05 pm
States with laws mandating flu shots for hospital workers saw reductions in deaths from influenza and pneumonia across their populations, a study published Friday by the Annals of Internal Medicine ...
- Nine reasons why Israel leads the world in vaccine distributionon January 3, 2021 at 10:49 am
Universal healthcare Universal healthcare has existed in Israel ... This year, even before the coronavirus vaccination, Clalit used these mechanisms to provide influenza vaccines to patients at ...
- Colorado bioscience companies ramp up vaccine development in 2021on December 31, 2020 at 7:25 am
One of the biggest news items of the year in 2021 — and the biggest story in biotech – will be the Covid-19 vaccine. Several Colorado companies are working on either second-generation vaccines — ...
- How Scientists Tried to Find a Universal Flu Vaccineon December 27, 2020 at 5:18 am
In 1936, journalist Paul de Kruif made a bold prediction: Medical science was about to conquer influenza. Among scientists and journalists alike, hopes were high after a series of successes isolating ...
via Bing News